Tenet Healthcare Corporation (THC) Stock

Understand Tenet Healthcare Corporation: how it makes money

Tenet runs a network of for-profit hospitals and ambulatory surgery centers, earning revenue from patient service fees paid by insurers and self-pay patients. Roughly three-quarters of revenue comes from inpatient hospital care, while a growing USPI partnership model is shifting joint-replacement procedures to higher-margin outpatient centers.

The profit engine is the USPI partnership: Tenet supplies surgeons to USPI-owned surgery centers for joint replacements, capturing high-margin procedural revenue without the capital cost of building and staffing hospitals. This converts what would be inpatient capital expenditure into fee-for-service surgical volume.

Business quality (Strong): Solid operator: 27% operating margin, 7% revenue growth, and a growing ambulatory franchise. However, the stock trades at 7x earnings versus a 25x industry average, meaning the market has already priced in significant payor-mix deterioration and regulatory risk.

Valuation: At 7× earnings, THC trades 72% below the Healthcare Services average (25×). Note: the low multiple may reflect one-time earnings items.

Bull case

• Outpatient joint-replacement engine scaling: Management cited strong joint-replacement growth and a robust USPI partnership pipeline. Ambulatory same-facility revenue grew 7.7% and revenue per surgical case rose 8.3%, confirming the model expands procedure volume without adding hospital capex.
• Deep discount to sector multiples: THC trades at 7.0x earnings versus the Healthcare Services industry average of 25.4x, a 72% discount. If exchange-driven volume concerns moderate, the multiple has substantial room to re-rate toward peers without the stock needing to outgrow its business.
• Cost programs guard the margin base: Management outlined productivity gains, clinical operations improvements, and AI-driven automation as ongoing margin levers. With operating margin already at 27%, these initiatives provide a buffer that can absorb inpatient volume softness without compressing EBITDA.

Bear case

• Exchange volume collapse hitting the core: Same-hospital exchange admissions fell 13.5% with uninsured volumes rising proportionately, and management expects the erosion to continue through the latter half of the year. Because hospitals generate 72% of Tenet's revenue, sustained payor-mix shifts directly compress inpatient volume and elective-surgery pipelines in affected states.
• 340B rule change is a real tail risk: Proposed changes to the 340B drug-pricing program remain financially material and legally uncertain. A restrictive ruling would cut pharmacy revenue at both hospital and ambulatory sites with no offsetting source, and the timing is outside management's control.

Related Companies (Healthcare Services; 8 comparable companies)

• Universal Health Services, Inc. (UHS)
• Community Health Systems, Inc. (CYH)
• Ardent Health Partners, LLC (ARDT)
• HCA Healthcare, Inc. (HCA)
• Surgery Partners, Inc. (SGRY)
• DaVita Inc. (DVA)
• BrightSpring Health Services, Inc. Common Stock (BTSG)
• Encompass Health Corporation (EHC)